Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study - Articles - Infectiology · Anesthesiology · Pain

Viral Infections, Non-HIV

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

Int J Med Sci.

Pan F, Yang L, Li Y, Liang B, Li L, Ye T, Li L, Liu D, Gui S, Hu Y, Zheng C

doi: 10.7150/ijms.46614.

Viral Infections, Non-HIV

Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study

Swiss Med Wkly

Sava M, Sommer G, Daikeler T, Woischnig AK, Martinez AE, Leuzinger K, Hirsch H, Erlanger T, Wiencierz A, Bassetti S, Tamm M, Tschudin-Sutter S, Stoeckle M, Pargger H, Siegemund M, Boss R, Zimmer G, Vu DL, Kaiser L, Dell-Kuster S, Weisser M, Battegay M, Hostettler K, Khanna N

doi: 10.4414/smw.2021.20550

Viral Infections, Non-HIV

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID)

Clin Microbiol Infect

Abelenda-Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, Rodríguez-Molinero A, Izquierdo E, Díaz-Brito V, Sanmartí M, Padullés A, Grau I, Ras MM, Bergas A, Guillem L, Blanco-Arévalo A, Alvarez-Pouso C, Pallarés N, Videla S, Tebé C, Carratalà J

doi: 10.1016/j.cmi.2021.06.041

Viral Infections, Non-HIV

Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies

Eur Heart J Acute Cardiovasc Care.

Parohan M, Yaghoubi S, Seraji A

doi: 10.1177/2048872620937165.

Viral Infections, Non-HIV

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Infect Dis Ther

Ruiz-Antorán B, Sancho-López A, Torres F, Moreno-Torres V, de Pablo-López I, García-López P, Abad-Santos F, Rosso-Fernández CM, Aldea-Perona A, Montané E, Aparicio-Hernández RM, Llop-Rius R, Pedrós C, Gijón P, Hernández-Carballo C, Pedrosa-Martínez MJ, Rodríguez-Jiménez C, Prada-Ramallal G, Cabrera-García L, Aguilar-García JA, Sanjuan-Jimenez R, Ortiz-Barraza EI, Sánchez-Chica E, Fernández-Cruz A, TOCICOV-study group.

doi: 10.1007/s40121-020-00373-8

Viral Infections, Non-HIV

Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Am J Med Sci.

Huang M, Yang Y, Shang F, Zheng Y, Zhao W, Luo L, Han X, Lin A, Zhao H, Gu Q, Shi Y, Li J, Xu X, Liu K, Deng Y, Cao Q, Wang W

doi: 10.1016/j.amjms.2020.05.038.

Viral Infections, Non-HIV

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Eur J Intern Med.

Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L, TOCI-RAF Study Group.

doi: 10.1016/j.ejim.2020.05.021.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

Lancet Respir Med.

Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, Klauber J, Janssens U, Marx G, Weber-Carstens S, Kluge S, Pfeifer M, Grabenhenrich L, Welte T, Busse R

doi: 10.1016/S2213-2600(20)30316-7.

Related content

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID)

Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study